Native-led • Pre-protocol intelligence • Tulsa, Oklahoma

Clinical trials should be designed for the people they intend to serve.

P.A.R.T.N.E.R. BioResearch is developing a pre-protocol clinical trial intelligence platform that helps research teams identify operational and community barriers earlier—so trials can be designed for feasibility, access, and trust from day one.

Pre-protocol intelligenceCommunity-centered designHuman-led decisions

Our story in motion

See why community-centered research matters.

This original P.A.R.T.N.E.R. feature shares the people, purpose, and perspective behind our work.

The problem

Research failure is often visible before enrollment starts.

Protocols can be scientifically sound and still fail operationally. Site readiness, visit burden, transportation, trust, digital access, consent, and local governance are too often treated as downstream recruitment problems instead of upstream design inputs.

01

Late feasibility insight

Critical patient and community barriers surface after protocol decisions are expensive to change.

02

Fragmented trust

Communities are asked to participate without transparent, durable control over how data and research authority are exercised.

03

Unequal access

Underrepresented communities face structural barriers that conventional site-selection models do not adequately capture.

The platform

One intelligence layer. Four connected perspectives.

P.A.R.T.N.E.R. turns scattered feasibility signals into reviewable decision support for sponsors, research sites, Tribal Nations, and patients.

Tribal authority

Sovereignty by design.

Governance, consent, purpose-of-use, review, and audit are modeled as enforceable workflow boundaries—not a future compliance add-on.

Site readiness

Operational reality, surfaced.

Translate protocol requirements into site burden, workforce, community partnership, and patient-support considerations.

Patient access

Plain language. Real agency.

Help people understand research opportunities, participation expectations, rights, and consent without reducing them to recruitment targets.

Investor snapshot

A focused entry point into a costly, persistent trial problem.

P.A.R.T.N.E.R. enters before protocol decisions and recruitment spend are locked in, creating value for sponsors while building a more credible path to community participation.

01

Customer

Biopharma sponsors, CROs, research sites, and health partners responsible for feasibility, enrollment, and retention.

02

Product wedge

Pre-protocol decision support for barrier forecasting, site and community readiness, engagement design, and reviewable risk intelligence.

03

Business model

Planned enterprise SaaS and pilot engagements, with implementation and partnership support matched to study complexity.

04

Defensibility

A Native-led, trust-centered operating model that combines domain knowledge, structured barrier intelligence, and governance-aware workflows.

Investment thesis

Move feasibility intelligence upstream, make community context operational, and turn trust from a late recruitment expense into an early design advantage.

Trust architecture

Intelligence without surrendering authority.

The technical strategy is deliberately governed: bounded AI, role-aware workflows, decision receipts, and a synthetic FHIR metadata path designed to prove controls before sensitive data enters scope.

See current boundaries
01Tribal authorityCommunity governance remains human-owned and revocable.
02Purpose-bound accessRole, entity, consent, and intended use shape every governed request.
03Explainable AIAI assists analysis; it does not approve research or make clinical decisions.
04AuditabilityReview states and decision evidence are designed to remain visible.

Current stage

Early enough to shape. Focused enough to pilot.

Early-stage • Product and partner development

P.A.R.T.N.E.R. is developing its pre-protocol intelligence and community engagement model in Tulsa, Oklahoma. We are building relationships with research organizations, Tribal leaders, healthcare professionals, funders, and technical partners who want feasibility and trust designed into trials earlier.

Near-term milestones

  • Validate priority workflows with design partners
  • Structure controlled pilot engagements
  • Expand the barrier intelligence framework
  • Measure decision quality and operational value

Operating discipline

  • Community voice before assumptions
  • Decision support—not autonomous approval
  • Transparent boundaries and human review
  • Partnership before scale

“Clinical research does not fail only because of science. It fails when we forget the human layer.”

Kelsey Elizabeth PowellFounder & inventor • Muscogee (Creek) Nation citizen

Invest • Pilot • Partner

Better feasibility starts before the protocol is final.

We welcome conversations with aligned investors, Tribal health leaders, research sites, sponsors, funders, and technical partners. Request the company overview or discuss a design-partner pilot.